30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bruns Ingmar

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 6%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Bruns Ingmar's trades of Zentalis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
S Sale
50,139 -3.9%
405.55
US$3,357,912 		50,139 -3.9% 405.55 US$3,357,912
2026-02-10 2026-02-06
S Sale
45,395 -18.3%
467.33
US$2,122,217 		45,395 -18.3% 467.33 US$2,122,217
2025-02-12 2025-02-06
B Purchase
93,168 +49.7%
197.56
US$832,366 		93,168 +49.7% 197.56 US$832,366